ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $290K of Arcutis Biotherapeutics, Inc.
Sold$289,606
$28.96Price
10,000Shares
−13%Stake
What ARQT did after the filing
- The stock from Wed, Jan 7 open, $29.37
- −13.5%
- S&P 500, same days
- −0.4%
Measured over 30 trading days, to the Feb 20 close.
Traded Fri, Jan 2. Filed Tue, Jan 6, 5:31 PM ET, after the close. Returns use the Jan 7 open and the Feb 20 close. Not investment advice.